For clinical practice, T2DM patients seeking to enhance mitochondrial antioxidant capacity can choose either modality, though longer moderate-intensity training may offer broader benefits by also increasing GPX1 and PRDX5. Here, GPX1 is linked to type 2 diabetes mellitus.